ONTOLOGY REPORT - ANNOTATIONS
| Term: | vanadyl sulfate |
|
| Accession: | CHEBI:33146
|
browse the term
|
| Definition: | An inorganic sulfate salt that has formula O5SV. |
| Synonyms: | exact_synonym: | oxidovanadium(2+) sulfate; oxovanadium(2+) sulfate |
| | related_synonym: | InChI=1S/H2O4S.O.V/c1-5(2,3)4;;/h(H2,1,2,3,4);;/q;;+2/p-2; InChIKey=UUUGYDOQQLOJQA-UHFFFAOYSA-L; O5SV; O=[V++].[O-]S([O-])(=O)=O; oxo[sulfato(2-)-O]-vanadium; oxo[sulfato(2-)-kappaO]-vanadium; vanadic sulfate; vanadin(IV) oxide sulfate; vanadium oxide sulphate; vanadium oxysulfate |
| | xref_casrn: | 27774-13-6 |
| | xref: | ChemIDplus:27774-13-6 "CAS Registry Number"; Gmelin:18096 "Gmelin Registry Number" |
| | xref_mesh: | MESH:C034028 |
|
|
vanadyl sulfate
|
| G |
Acpp |
acid phosphatase, prostate |
|
decreases expression |
ISO |
8 |
109,354,381 |
109,400,296 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases expression |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Angptl1 |
angiopoietin-like 1 |
|
increases expression |
ISO |
13 |
72,039,198 |
72,045,772 |
RGD:6480464 |
CTD |
| G |
Ankrd1 |
ankyrin repeat domain 1 |
|
multiple interactions |
EXP |
1 |
240,316,123 |
240,324,804 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
multiple interactions |
EXP |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Aqp7 |
aquaporin 7 |
|
multiple interactions |
EXP |
5 |
58,433,731 |
58,447,853 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
decreases expression |
ISO |
2 |
190,333,978 |
190,391,015 |
RGD:6480464 |
CTD |
| G |
Arrdc3 |
arrestin domain containing 3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Arrdc4 |
arrestin domain containing 4 |
|
decreases expression |
ISO |
1 |
123,522,706 |
123,531,698 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
increases phosphorylation |
ISO |
3 |
56,403,676 |
56,496,473 |
RGD:6480464 |
CTD |
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
decreases expression |
ISO |
11 |
79,006,123 |
79,030,555 |
RGD:6480464 |
CTD |
| G |
Bcor |
BCL6 co-repressor |
|
decreases expression |
ISO |
X |
22,699,778 |
22,820,234 |
RGD:6480464 |
CTD |
| G |
C1qb |
complement component 1, q subcomponent, B chain |
|
multiple interactions |
EXP |
5 |
155,647,524 |
155,653,074 |
RGD:6480464 |
CTD |
| G |
C4b |
complement component 4B (Chido blood group) |
|
multiple interactions |
EXP |
20 |
4,300,687 |
4,315,882 |
RGD:6480464 |
CTD |
| G |
Cacng2 |
calcium channel, voltage-dependent, gamma subunit 2 |
|
increases expression |
ISO |
7 |
115,913,440 |
116,037,891 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
decreases expression |
ISO |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
increases expression |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
decreases expression |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Cinp |
cyclin-dependent kinase 2-interacting protein |
|
decreases expression |
ISO |
6 |
135,595,588 |
135,609,484 |
RGD:6480464 |
CTD |
| G |
Cirbp |
cold inducible RNA binding protein |
|
decreases expression |
ISO |
7 |
11,047,003 |
11,050,820 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions |
EXP |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Ckmt2 |
creatine kinase, mitochondrial 2, sarcomeric |
|
multiple interactions |
EXP |
2 |
22,084,948 |
22,106,014 |
RGD:6480464 |
CTD |
| G |
Cldn1 |
claudin 1 |
|
increases expression |
ISO |
11 |
76,473,654 |
76,488,809 |
RGD:6480464 |
CTD |
| G |
Cldn4 |
claudin 4 |
|
increases expression |
ISO |
12 |
22,816,134 |
22,817,932 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
multiple interactions |
EXP |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpvl |
carboxypeptidase, vitellogenic-like |
|
increases expression |
ISO |
4 |
82,238,756 |
82,344,130 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
decreases expression |
ISO |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csnk1d |
casein kinase 1, delta |
|
increases expression |
ISO |
10 |
110,166,244 |
110,197,233 |
RGD:6480464 |
CTD |
| G |
Csrp3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
|
multiple interactions |
EXP |
1 |
98,601,681 |
98,611,747 |
RGD:6480464 |
CTD |
| G |
Ctsg |
cathepsin G |
|
increases expression |
ISO |
15 |
34,622,211 |
34,624,798 |
RGD:6480464 |
CTD |
| G |
Ctss |
cathepsin S |
|
multiple interactions |
EXP |
2 |
190,425,290 |
190,466,877 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
increases expression |
ISO |
14 |
18,767,306 |
18,787,340 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
decreases expression |
ISO |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Ddx39b |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B |
|
decreases expression |
ISO |
20 |
3,611,128 |
3,623,578 |
RGD:6480464 |
CTD |
| G |
Decr1 |
2,4-dienoyl CoA reductase 1, mitochondrial |
|
multiple interactions |
EXP |
5 |
30,492,196 |
30,520,172 |
RGD:6480464 |
CTD |
| G |
Denr |
density-regulated protein |
|
decreases expression |
ISO |
12 |
33,797,483 |
33,819,744 |
RGD:6480464 |
CTD |
| G |
Drp2 |
dystrophin related protein 2 |
|
increases expression |
ISO |
X |
121,881,801 |
121,929,386 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp21 |
dual specificity phosphatase 21 |
|
increases expression |
ISO |
X |
16,064,183 |
16,065,039 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
increases expression |
ISO |
1 |
259,754,234 |
259,767,645 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases phosphorylation |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
increases activity |
ISO |
X |
12,597,863 |
12,604,248 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
multiple interactions |
ISO |
X |
12,597,863 |
12,604,248 |
RGD:6480464 |
CTD |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
increases expression |
ISO |
5 |
168,012,683 |
168,025,963 |
RGD:6480464 |
CTD |
| G |
Fbxo5 |
F-box protein 5 |
|
decreases expression |
ISO |
1 |
36,492,134 |
36,498,503 |
RGD:6480464 |
CTD |
| G |
Fgd6 |
FYVE, RhoGEF and PH domain containing 6 |
|
increases expression |
ISO |
7 |
31,160,021 |
31,286,379 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
increases expression |
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fyb |
FYN binding protein |
|
decreases expression |
ISO |
2 |
55,858,764 |
55,950,014 |
RGD:6480464 |
CTD |
| G |
Galt |
galactose-1-phosphate uridylyltransferase |
|
decreases expression |
ISO |
5 |
59,185,418 |
59,188,642 |
RGD:6480464 |
CTD |
| G |
Gcnt2 |
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
|
increases expression |
ISO |
17 |
29,767,383 |
29,808,950 |
RGD:6480464 |
CTD |
| G |
Gpr137b |
G protein-coupled receptor 137B |
|
decreases expression |
ISO |
17 |
66,993,915 |
67,004,339 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
multiple interactions |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
multiple interactions |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
increases expression |
ISO |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
increases expression |
ISO |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
multiple interactions |
EXP |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
decreases expression |
ISO |
4 |
79,700,327 |
79,704,116 |
RGD:6480464 |
CTD |
| G |
Hoxd9 |
homeo box D9 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hs3st1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 1 |
|
increases expression |
ISO |
14 |
76,438,219 |
76,439,157 |
RGD:6480464 |
CTD |
| G |
Ica1 |
islet cell autoantigen 1 |
|
decreases expression |
ISO |
4 |
33,680,878 |
33,830,443 |
RGD:6480464 |
CTD |
| G |
Icam2 |
intercellular adhesion molecule 2 |
|
increases expression |
ISO |
10 |
95,772,448 |
95,779,071 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
decreases expression |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Ifne |
interferon, epsilon |
|
increases expression |
ISO |
5 |
108,451,998 |
108,452,573 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r1 |
interleukin 1 receptor, type I |
|
increases expression |
ISO |
9 |
39,434,910 |
39,473,552 |
RGD:6480464 |
CTD |
| G |
Il1r2 |
interleukin 1 receptor, type II |
|
increases expression |
ISO |
9 |
39,279,397 |
39,319,672 |
RGD:6480464 |
CTD |
| G |
Il36g |
interleukin 36, gamma |
|
increases expression |
ISO |
3 |
2,432,285 |
2,438,437 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Impa2 |
inositol (myo)-1(or 4)-monophosphatase 2 |
|
multiple interactions |
EXP |
18 |
63,809,336 |
63,840,069 |
RGD:6480464 |
CTD |
| G |
Itpr3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
|
increases expression |
ISO |
20 |
5,292,430 |
5,357,502 |
RGD:6480464 |
CTD |
| G |
Jam2 |
junctional adhesion molecule 2 |
|
increases expression |
ISO |
11 |
24,310,704 |
24,315,219 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases phosphorylation |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kbtbd6 |
kelch repeat and BTB (POZ) domain containing 6 |
|
decreases expression |
ISO |
15 |
61,501,576 |
61,503,070 |
RGD:6480464 |
CTD |
| G |
Kctd6 |
potassium channel tetramerisation domain containing 6 |
|
decreases expression |
ISO |
15 |
18,680,992 |
18,684,394 |
RGD:6480464 |
CTD |
| G |
Kdm4d |
lysine (K)-specific demethylase 4D |
|
increases expression |
ISO |
8 |
11,222,556 |
11,247,715 |
RGD:6480464 |
CTD |
| G |
Klhl41 |
kelch-like family member 41 |
|
increases expression |
ISO |
3 |
51,816,016 |
51,829,140 |
RGD:6480464 |
CTD |
| G |
Krt36 |
keratin 36 |
|
increases expression |
ISO |
10 |
89,041,712 |
89,045,077 |
RGD:6480464 |
CTD |
| G |
Krt86 |
keratin 86 |
|
increases expression |
ISO |
7 |
140,222,555 |
140,228,828 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
multiple interactions |
EXP |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lhx9 |
LIM homeobox 9 |
|
decreases expression |
ISO |
13 |
52,143,492 |
52,160,922 |
RGD:6480464 |
CTD |
| G |
Lif |
leukemia inhibitory factor |
|
increases expression |
ISO |
14 |
84,887,856 |
84,890,630 |
RGD:6480464 |
CTD |
| G |
Lins |
lines homolog (Drosophila) |
|
decreases expression |
ISO |
1 |
121,162,852 |
121,169,099 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
multiple interactions |
EXP |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
increases phosphorylation |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
multiple interactions |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
multiple interactions |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
increases phosphorylation |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
decreases expression |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mchr1 |
melanin-concentrating hormone receptor 1 |
|
increases expression |
ISO |
7 |
119,557,141 |
119,559,619 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
increases expression |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp25 |
matrix metallopeptidase 25 |
|
increases expression |
ISO |
10 |
12,894,707 |
12,907,837 |
RGD:6480464 |
CTD |
| G |
Mras |
muscle RAS oncogene homolog |
|
multiple interactions |
ISO |
8 |
104,244,660 |
104,272,556 |
RGD:6480464 |
CTD |
| G |
Mras |
muscle RAS oncogene homolog |
|
increases activity |
ISO |
8 |
104,244,660 |
104,272,556 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Myh3 |
myosin, heavy chain 3, skeletal muscle, embryonic |
|
multiple interactions |
EXP |
10 |
53,776,858 |
53,800,677 |
RGD:6480464 |
CTD |
| G |
Myo3b |
myosin IIIB |
|
decreases expression |
ISO |
3 |
52,249,255 |
52,645,911 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases degradation |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases degradation |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases phosphorylation |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases degradation |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
increases degradation |
ISO |
1 |
83,865,440 |
83,873,010 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
increases expression |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
decreases expression |
ISO |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
Pak6 |
p21 protein (Cdc42/Rac)-activated kinase 6 |
|
decreases expression |
ISO |
3 |
105,141,150 |
105,191,676 |
RGD:6480464 |
CTD |
| G |
Pdcd6 |
programmed cell death 6 |
|
increases expression |
ISO |
1 |
29,769,911 |
29,785,577 |
RGD:6480464 |
CTD |
| G |
Pde4dip |
phosphodiesterase 4D interacting protein |
|
increases expression |
ISO |
2 |
192,534,747 |
192,671,053 |
RGD:6480464 |
CTD |
| G |
Pdk2 |
pyruvate dehydrogenase kinase, isozyme 2 |
|
increases expression |
ISO |
10 |
83,710,448 |
83,724,973 |
RGD:6480464 |
CTD |
| G |
Pdlim3 |
PDZ and LIM domain 3 |
|
increases expression |
ISO |
16 |
49,637,068 |
49,668,802 |
RGD:6480464 |
CTD |
| G |
Pdxp |
pyridoxal (pyridoxine, vitamin B6) phosphatase |
|
decreases expression |
ISO |
7 |
116,880,751 |
116,886,199 |
RGD:6480464 |
CTD |
| G |
Pla2g12b |
phospholipase A2, group XIIB |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pla2g1b |
phospholipase A2, group IB, pancreas |
|
increases expression |
ISO |
12 |
42,405,475 |
42,415,189 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
increases expression |
ISO |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Plekhb1 |
pleckstrin homology domain containing, family B (evectins) member 1 |
|
increases expression |
ISO |
1 |
158,081,932 |
158,096,197 |
RGD:6480464 |
CTD |
| G |
Pml |
promyelocytic leukemia |
|
decreases expression |
ISO |
8 |
62,020,438 |
62,051,927 |
RGD:6480464 |
CTD |
| G |
Polr3g |
polymerase (RNA) III (DNA directed) polypeptide G |
|
increases expression |
ISO |
2 |
9,763,378 |
9,804,285 |
RGD:6480464 |
CTD |
| G |
Ppef2 |
protein phosphatase, EF hand calcium-binding domain 2 |
|
increases expression |
ISO |
14 |
17,359,298 |
17,392,820 |
RGD:6480464 |
CTD |
| G |
Ppp1r10 |
protein phosphatase 1, regulatory subunit 10 |
|
increases expression |
ISO |
20 |
2,940,605 |
2,984,636 |
RGD:6480464 |
CTD |
| G |
Prdm1 |
PR domain containing 1, with ZNF domain |
|
increases expression |
ISO |
20 |
48,438,224 |
48,459,848 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
decreases expression |
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
|
decreases activity |
ISO |
3 |
159,070,473 |
159,116,792 |
RGD:6480464 |
CTD |
| G |
Ptpre |
protein tyrosine phosphatase, receptor type, E |
|
increases expression |
ISO |
1 |
195,263,489 |
195,303,249 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
decreases expression |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rars2 |
arginyl-tRNA synthetase 2, mitochondrial |
|
increases expression |
ISO |
5 |
51,226,723 |
51,268,906 |
RGD:6480464 |
CTD |
| G |
Rce1 |
RCE1 homolog, prenyl protein protease (S. cerevisiae) |
|
increases expression |
ISO |
1 |
207,213,714 |
207,216,814 |
RGD:6480464 |
CTD |
| G |
Rchy1 |
ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
14 |
17,683,377 |
17,698,982 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
increases expression |
ISO |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rhoj |
ras homolog family member J |
|
increases expression |
ISO |
6 |
97,911,744 |
97,995,878 |
RGD:6480464 |
CTD |
| G |
Rims3 |
regulating synaptic membrane exocytosis 3 |
|
decreases expression |
ISO |
5 |
141,449,059 |
141,477,301 |
RGD:6480464 |
CTD |
| G |
Rpl13 |
ribosomal protein L13 |
|
increases expression |
ISO |
19 |
53,437,633 |
53,440,184 |
RGD:6480464 |
CTD |
| G |
Rpl18a |
ribosomal protein L18A |
|
multiple interactions |
EXP |
16 |
19,042,063 |
19,044,069 |
RGD:6480464 |
CTD |
| G |
Rps3 |
ribosomal protein S3 |
|
multiple interactions |
EXP |
1 |
156,811,470 |
156,816,770 |
RGD:6480464 |
CTD |
| G |
Rrad |
Ras-related associated with diabetes |
|
multiple interactions |
EXP |
19 |
272,791 |
275,957 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
decreases expression |
ISO |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
S1pr3 |
sphingosine-1-phosphate receptor 3 |
|
increases expression |
ISO |
17 |
19,657,822 |
19,661,106 |
RGD:6480464 |
CTD |
| G |
Scarf2 |
scavenger receptor class F, member 2 |
|
decreases expression |
ISO |
11 |
85,164,352 |
85,175,734 |
RGD:6480464 |
CTD |
| G |
Sdccag8 |
serologically defined colon cancer antigen 8 |
|
decreases expression |
ISO |
13 |
92,612,281 |
92,802,650 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
increases expression |
ISO |
13 |
13,632,596 |
13,641,605 |
RGD:6480464 |
CTD |
| G |
Serpini2 |
serpin peptidase inhibitor, clade I (pancpin), member 2 |
|
increases expression |
ISO |
2 |
166,104,307 |
166,133,835 |
RGD:6480464 |
CTD |
| G |
Siglec8 |
sialic acid binding Ig-like lectin 8 |
|
increases expression |
ISO |
1 |
94,062,030 |
94,071,181 |
RGD:6480464 |
CTD |
| G |
Six1 |
SIX homeobox 1 |
|
decreases expression |
ISO |
6 |
95,470,153 |
95,475,389 |
RGD:6480464 |
CTD |
| G |
Six2 |
SIX homeobox 2 |
|
decreases expression |
ISO |
6 |
9,094,655 |
9,097,973 |
RGD:6480464 |
CTD |
| G |
Slc13a3 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 |
|
increases expression |
ISO |
3 |
156,447,900 |
156,510,620 |
RGD:6480464 |
CTD |
| G |
Slc26a3 |
solute carrier family 26, member 3 |
|
decreases expression |
ISO |
6 |
49,305,008 |
49,346,008 |
RGD:6480464 |
CTD |
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
multiple interactions |
EXP |
16 |
18,769,909 |
18,786,988 |
RGD:6480464 |
CTD |
| G |
Smad4 |
SMAD family member 4 |
|
decreases expression |
ISO |
18 |
70,432,705 |
70,461,541 |
RGD:6480464 |
CTD |
| G |
Sncg |
synuclein, gamma (breast cancer-specific protein 1) |
|
multiple interactions |
EXP |
16 |
10,025,978 |
10,030,516 |
RGD:6480464 |
CTD |
| G |
Sox2 |
SRY (sex determining region Y)-box 2 |
|
decreases expression |
ISO |
2 |
120,969,021 |
120,971,430 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
|
multiple interactions |
EXP |
4 |
105,373,385 |
105,432,192 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases expression |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stau2 |
staufen, RNA binding protein, homolog 2 (Drosophila) |
|
decreases expression |
ISO |
5 |
2,084,331 |
2,182,359 |
RGD:6480464 |
CTD |
| G |
Ston1 |
stonin 1 |
|
increases expression |
ISO |
6 |
12,473,166 |
12,490,453 |
RGD:6480464 |
CTD |
| G |
Stx6 |
syntaxin 6 |
|
increases expression |
ISO |
13 |
70,121,864 |
70,169,379 |
RGD:6480464 |
CTD |
| G |
Taf6l |
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor |
|
decreases expression |
ISO |
1 |
211,445,311 |
211,457,839 |
RGD:6480464 |
CTD |
| G |
Tbx1 |
T-box 1 |
|
decreases expression |
ISO |
11 |
84,400,980 |
84,410,631 |
RGD:6480464 |
CTD |
| G |
Terf2 |
telomeric repeat binding factor 2 |
|
decreases expression |
ISO |
19 |
36,930,490 |
36,958,589 |
RGD:6480464 |
CTD |
| G |
Thbs4 |
thrombospondin 4 |
|
multiple interactions |
EXP |
2 |
23,010,823 |
23,053,527 |
RGD:6480464 |
CTD |
| G |
Tifa |
TRAF-interacting protein with forkhead-associated domain |
|
decreases expression |
ISO |
2 |
225,067,695 |
225,076,898 |
RGD:6480464 |
CTD |
| G |
Tor2a |
torsin family 2, member A |
|
decreases expression |
ISO |
3 |
11,733,950 |
11,738,016 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
decreases expression |
ISO |
8 |
71,331,304 |
71,358,063 |
RGD:6480464 |
CTD |
| G |
Tpp2 |
tripeptidyl peptidase II |
|
decreases expression |
ISO |
9 |
42,984,834 |
43,066,195 |
RGD:6480464 |
CTD |
| G |
Trex1 |
three prime repair exonuclease 1 |
|
increases expression |
ISO |
8 |
114,071,508 |
114,072,509 |
RGD:6480464 |
CTD |
| G |
Wars2 |
tryptophanyl tRNA synthetase 2 (mitochondrial) |
|
increases expression |
ISO |
2 |
193,819,862 |
193,902,421 |
RGD:6480464 |
CTD |
| G |
XAF1 |
XIAP associated factor-1 |
|
decreases expression |
ISO |
10 |
59,185,150 |
59,196,549 |
RGD:6480464 |
CTD |
| G |
Zbtb1 |
zinc finger and BTB domain containing 1 |
|
decreases expression |
ISO |
6 |
98,981,038 |
98,984,303 |
RGD:6480464 |
CTD |
| G |
Zbtb24 |
zinc finger and BTB domain containing 24 |
|
decreases expression |
ISO |
20 |
45,409,557 |
45,426,510 |
RGD:6480464 |
CTD |
| G |
Zdhhc21 |
zinc finger, DHHC-type containing 21 |
|
decreases expression |
ISO |
5 |
101,682,165 |
101,730,978 |
RGD:6480464 |
CTD |
| G |
Zfp46 |
zinc finger protein 46 |
|
decreases expression |
ISO |
5 |
155,035,876 |
155,040,376 |
RGD:6480464 |
CTD |
| G |
Zfp503 |
zinc finger protein 503 |
|
decreases expression |
ISO |
15 |
2,352,911 |
2,356,699 |
RGD:6480464 |
CTD |
| G |
Zkscan3 |
zinc finger with KRAB and SCAN domains 3 |
|
increases expression |
ISO |
17 |
50,862,534 |
50,901,252 |
RGD:6480464 |
CTD |
Term paths to the root
|